Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

US Supplement Firm Warnings Up, Enforcement Tools Idle, Hemp and NAC Still In Limbo

Apr 05 2022

• By Hannah Daniel

• Source: Alamy

Related Content

NPA Petitions US FDA To Act On CBD Regulation

Feb 23 2022

Children's Use Of New Earth Healing's Colloidal Silver Eye Drops, Nasal Sprays Concerns US FDA

Feb 16 2022

NAC Gains Tentative Safety Clearance As US Industry Contests FDA's Attempt To Remove It

Mar 31 2022

US Cannabis Legalization Cultivated By House Has Thorny Forecast For Harvest In Senate

Apr 04 2022

CBD Market Provides ‘Enormous Incentive’ For FDA's Regulatory Answer But Decision Remains TBD

Dec 10 2020

AHPA Offers Hard Copy Supporting NAC's Use In Dietary Supplements Pre-DSHEA

Oct 13 2021

In NAC Docket, NAD+ Drug Firm Suggests US FDA Get Serious About Dietary Ingredient Regulations

Dec 07 2021

Additional Topics

US States FDA Regulation Warning Letters Cannabidiol CBD Compliance Consumer Coronavirus COVID-19 Dietary Supplements Enforcement Guidance Documents OTC Drugs Policy

More from Regulation

More from Policy & Regulation

Twitter feed RSS feed RSS feed

About UsOpens in new window
Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us
Customer Service
Subscribe
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window